US 7429616
Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds
granted A61PA61P35/00A61P35/02
Quick answer
US patent 7429616 (Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds) held by The Board of Regents of the University of Texas System expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P43/00